We are live on
!
Find out more
Jacobs Levy Equity Management Portfolio holdings
AUM
$23.8B
1-Year Est. Return
25.4%
This Fund
S&P 500
This Quarter
Est. Return
-1.9%
1 Year Est. Return
+25.4%
3 Year Est. Return
+87.35%
5 Year Est. Return
+125.75%
10 Year Est. Return
+515.94%
AUM
$4.72B
AUM Growth
-$313M
(-6.2%)
Cap. Flow
-$247M
Cap. Flow
% of AUM
-5.24%
Top 10 Holdings %
Top 10 Hldgs %
13.35%
Holding
1,246
New
455
Increased
271
Reduced
328
Closed
160
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Alphabet (Google) Class C
GOOG
|
+$32.6M |
| 2 |
ARRS
ARRIS International plc Ordinary Shares
ARRS
|
+$31.7M |
| 3 |
ENDP
Endo International plc
ENDP
|
+$28.2M |
| 4 |
Targa Resources
TRGP
|
+$25.3M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$21.2M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Merck
MRK
|
+$50.8M |
| 2 |
Walt Disney
DIS
|
+$49.8M |
| 3 |
Accenture
ACN
|
+$41.1M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$35.4M |
| 5 |
Valero Energy
VLO
|
+$30.2M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.19% |
| 2 | Financials | 16.07% |
| 3 | Healthcare | 13.89% |
| 4 | Consumer Discretionary | 12.13% |
| 5 | Industrials | 9.91% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
EQY
426
DELISTED
Equity One
EQY
| $1.8M | 0.04% |
62,960
+3,530
| +6% | +$96.9K |
|
|
SGNT
427
DELISTED
SAGENT PHARMACEUTICALS INC COM STK (DE)
SGNT
| $1.8M | 0.04% |
+148,114
| New | +$2.08M |
|
428
SPX Corp
SPXC
$11B
| $1.8M | 0.04% |
119,650
-92,218
| -44% | -$985K |
|
|
FLG
429
Flagstar Bank National Association
FLG
$5.77B
| $1.8M | 0.04% |
37,667
-8,840
| -19% | -$409K |
|
|
NXGN
430
DELISTED
NextGen Healthcare, Inc. Common Stock
NXGN
| $1.79M | 0.04% |
117,430
-27,710
| -19% | -$420K |
|
|
RTEC
431
DELISTED
Rudolph Technologies Inc
RTEC
| $1.76M | 0.04% |
128,641
-3,900
| -3% | -$49.2K |
|
|
BRS
432
DELISTED
Bristow Group, Inc.
BRS
| $1.74M | 0.04% |
+92,100
| New | +$1.71M |
|
433
AeroVironment
AVAV
$7.57B
| $1.74M | 0.04% |
61,442
+11,330
| +23% | +$296K |
|
434
NETGEAR
NTGR
$669M
| $1.74M | 0.04% |
43,065
-92,470
| -68% | -$3.56M |
|
|
CHMT
435
DELISTED
Chemtura Corporation
CHMT
| $1.74M | 0.04% |
65,839
-181,231
| -73% | -$4.63M |
|
|
CAA
436
DELISTED
CalAtlantic Group, Inc.
CAA
| $1.74M | 0.04% |
+51,960
| New | +$1.63M |
|
|
MDR
437
DELISTED
McDermott International
MDR
| $1.74M | 0.04% |
+141,373
| New | +$1.34M |
|
438
RenaissanceRe
RNR
$13.7B
| $1.73M | 0.04% |
14,457
| – | – |
|
|
JIVE
439
DELISTED
Jive Software, Inc.
JIVE
| $1.73M | 0.04% |
456,378
-30,407
| -6% | -$106K |
|
440
Dorian LPG
LPG
$1.94B
| $1.72M | 0.04% |
+183,436
| New | +$1.89M |
|
|
441
Accenture
ACN
$89.9B
| $1.72M | 0.04% |
14,860
-400,430
| -96% | -$41.1M |
|
442
Blackrock
BLK
$164B
| $1.72M | 0.04% |
5,037
-71,539
| -93% | -$22.7M |
|
443
Brunswick
BC
$5.19B
| $1.7M | 0.04% |
35,360
-95,309
| -73% | -$4.12M |
|
|
TIVO
444
DELISTED
Tivo Inc
TIVO
| $1.69M | 0.04% |
+82,460
| New | +$1.64M |
|
|
VWR
445
DELISTED
VWR Corporation
VWR
| $1.69M | 0.04% |
62,470
+47,750
| +324% | +$1.18M |
|
|
QGENF
446
DELISTED
QIAGEN NV
QGENF
| $1.68M | 0.04% |
75,373
-483,210
| -87% | -$10.8M |
|
447
National Bank Holdings
NBHC
$1.93B
| $1.68M | 0.04% |
82,376
+37,044
| +82% | +$733K |
|
448
Manhattan Associates
MANH
$8.97B
| $1.68M | 0.04% |
+29,490
| New | +$1.64M |
|
449
ScottsMiracle-Gro
SMG
$4.03B
| $1.68M | 0.04% |
23,040
-32,312
| -58% | -$2.2M |
|
|
ICPT
450
DELISTED
Intercept Pharmaceuticals, Inc.
ICPT
| $1.68M | 0.04% |
+13,040
| New | +$1.54M |
|
Similar funds
OAG
CHP
SAM
JG
Jacobs Levy Equity Management's Q1 2016 Portfolio in Review
As of Q1 2016, Jacobs Levy Equity Management held 1,246 positions worth $4.72B, down 6.2% from $5.03B the previous quarter. Its ten largest holdings account for 13% of the portfolio.
Jacobs Levy Equity Management withdrew a net $247M in Q1 2016, closing 160 positions and reducing 328 holdings. Its most notable exit was Merck, an estimated $50.8M position sold in full.
By sector, the portfolio is most concentrated in Technology at 16% of assets, down from 17% a quarter earlier, followed by Financials and Healthcare.
Against the trend, Jacobs Levy Equity Management opened a new position in Endo International plc worth $16.8M.
- Jacobs Levy Equity Management's largest Q1 2016 buy was Endo International plc: 596,209 shares worth $16.8M.
- Jacobs Levy Equity Management added most to Alphabet (Google) Class C in Q1 2016, an estimated $32.6M increase.
- Jacobs Levy Equity Management's biggest Q1 2016 reduction was Walt Disney, cutting an estimated $49.8M.
- Jacobs Levy Equity Management fully exited Merck in Q1 2016, selling an estimated $50.8M.
- Jacobs Levy Equity Management's ten largest holdings make up 13% of its $4.72B portfolio in Q1 2016.
- Jacobs Levy Equity Management opened 455 new positions and closed 160 in Q1 2016.
- Jacobs Levy Equity Management's portfolio value fell 6.2% quarter-over-quarter to $4.72B.
Based on Jacobs Levy Equity Management's 13F filing for Q1 2016, filed 16 May 2016.